Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo …
… chairman,6 John Morser, senior research scientist,5 Hiroyasu Kobayashi, assistant
professor and chief resident,1 Tetsu Kobayashi, assistant professor,1 Corina D’Alessandro-Gabazza, …
professor and chief resident,1 Tetsu Kobayashi, assistant professor,1 Corina D’Alessandro-Gabazza, …
A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial …
…, H Yuda, M Yoshida, H Kobayashi… - Clinical infectious …, 2013 - academic.oup.com
Background. Optimal empiric therapy for hospitalized patients with healthcare-associated
pneumonia (HCAP) is uncertain. Methods. We prospectively applied a therapeutic algorithm, …
pneumonia (HCAP) is uncertain. Methods. We prospectively applied a therapeutic algorithm, …
Home high-flow nasal cannula oxygen therapy for stable hypercapnic COPD: a randomized clinical trial
…, S Fuke, M Kagajo, H Nishine, H Kobayashi… - American Journal of …, 2022 - atsjournals.org
Rationale: The long-term effects of using a high-flow nasal cannula for chronic hypercapnic
respiratory failure caused by chronic obstructive pulmonary disease remain unclear. …
respiratory failure caused by chronic obstructive pulmonary disease remain unclear. …
Prognostic significance of plasma D-dimer levels in patients with lung cancer.
…, H Yasui, T Kobayashi, M Yoshida, H Kobayashi - Thorax, 1997 - thorax.bmj.com
BACKGROUND: The peripheral blood concentrations of several proteases of the clotting
system have been shown to predict survival in patients with malignancy. A study was …
system have been shown to predict survival in patients with malignancy. A study was …
A therapeutic strategy for all pneumonia patients: a 3-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial …
…, M Amishima, F Higa, H Kobayashi… - Clinical Infectious …, 2019 - academic.oup.com
Background Empiric therapy of pneumonia is currently based on the site of acquisition (community
or hospital), but could be chosen, based on risk factors for multidrug-resistant (MDR) …
or hospital), but could be chosen, based on risk factors for multidrug-resistant (MDR) …
Trans-splicing repair of CD40 ligand deficiency results in naturally regulated correction of a mouse model of hyper-IgM X-linked immunodeficiency
M Tahara, RG Pergolizzi, H Kobayashi, A Krause… - Nature medicine, 2004 - nature.com
X-linked immunodeficiency with hyper-IgM (HIGM1), characterized by failure of immunoglobulin
isotype switching, is caused by mutations of the CD40 ligand (CD40L), which is normally …
isotype switching, is caused by mutations of the CD40 ligand (CD40L), which is normally …
High plasma level of plasmin-α2-plasmin inhibitor complex is predictor of poor prognosis in patients with lung cancer
…, EC Gabazza, M Yoshida, T Yamakami, H Kobayashi… - Clinica chimica acta, 1996 - Elsevier
The occurrence of thrombotic complications is commonly associated with poor prognosis in
patients with malignancy. However, the prognostic significance of the subclinical activation of …
patients with malignancy. However, the prognostic significance of the subclinical activation of …
[HTML][HTML] Sequential therapy with crizotinib and alectinib in ALK-rearranged non–small cell lung cancer—a multicenter retrospective study
K Ito, O Hataji, H Kobayashi, A Fujiwara… - Journal of Thoracic …, 2017 - Elsevier
Introduction Alectinib and crizotinib have been approved for the therapy of NSCLC caused
by anaplastic lymphoma kinase gene (ALK) rearrangement. The effect of alectinib or …
by anaplastic lymphoma kinase gene (ALK) rearrangement. The effect of alectinib or …
Seasonal variation in the atmospheric deposition of inorganic constituents and canopy interactions in a Japanese cedar forest
H Sase, A Takahashi, M Sato, H Kobayashi… - Environmental …, 2008 - Elsevier
The seasonal changes in throughfall (TF) and stemflow (SF) chemistry and the canopy
interactions of K + and N compounds were studied in a Japanese cedar forest near the Sea of …
interactions of K + and N compounds were studied in a Japanese cedar forest near the Sea of …
Correlation between circulating fibrocytes, and activity and progression of interstitial lung diseases
A Fujiwara, H Kobayashi, M Masuya… - …, 2012 - Wiley Online Library
Background and objective: Interstitial lung diseases (ILD) are characterized by progressive
interstitial pulmonary fibrosis and a decline in lung function. Fibrocytes are bone marrow‐…
interstitial pulmonary fibrosis and a decline in lung function. Fibrocytes are bone marrow‐…